Previous close | 3.6000 |
Open | 3.6000 |
Bid | 3.2000 |
Ask | 3.4000 |
Strike | 20.00 |
Expiry date | 2024-10-18 |
Day's range | 3.6000 - 3.6000 |
Contract range | N/A |
Volume | |
Open interest | 228 |
PALO ALTO, Calif., May 07, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences.
Investors' focus will likely be on revenues generated by Guardant Health (GH) from its precision oncology testing business.
PALO ALTO, Calif., May 07, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its achievement of surpassing a significant milestone of 500 peer-reviewed publications featuring its technology in esteemed scientific journals. This milestone highlights Guardant Health’s leadership, amassing one of the most robust portfolios of relevant liquid biopsy research studies in the industry.